Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,244
datasets available to search
ShareScore release 0.9.0
Dataset results
10,244 results for “Vaccine”
Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants
ClinicalTrials.gov study NCT03343626. IPD Sharing: YES. Countries: 2. Publications: 2.
Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years
ClinicalTrials.gov study NCT04313244. IPD Sharing: YES. Countries: 1. Publications: 3.
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
ClinicalTrials.gov study NCT04852978. IPD Sharing: YES. Countries: 1. Publications: 1.
Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America
ClinicalTrials.gov study NCT00993447. IPD Sharing: YES. Countries: 4. Publications: 2.
Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Ye
ClinicalTrials.gov study NCT04936685. IPD Sharing: YES. Countries: 4. Publications: 1.
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier)
ClinicalTrials.gov study NCT04142242. IPD Sharing: YES. Countries: 2. Publications: 2.
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years
ClinicalTrials.gov study NCT03233217. IPD Sharing: YES. Countries: 1. Publications: 1.
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
ClinicalTrials.gov study NCT02199691. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
ClinicalTrials.gov study NCT01732627. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America
ClinicalTrials.gov study NCT01187433. IPD Sharing: YES. Countries: 1. Publications: 2.
Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-
ClinicalTrials.gov study NCT04969276. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
ClinicalTrials.gov study NCT00788151. IPD Sharing: YES. Countries: 1. Publications: 1.
Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
ClinicalTrials.gov study NCT05490329. IPD Sharing: YES. Countries: 1. Publications: 3.
Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
ClinicalTrials.gov study NCT01488890. IPD Sharing: YES. Countries: 1. Publications: 1.
Immunologic Response to Influenza Vaccination in Children and Adolescents
ClinicalTrials.gov study NCT03614975. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore
ClinicalTrials.gov study NCT00880893. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
ClinicalTrials.gov study NCT02915302. IPD Sharing: YES. Countries: 2. Publications: 1.
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults
ClinicalTrials.gov study NCT04498832. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older
ClinicalTrials.gov study NCT04904549. IPD Sharing: YES. Countries: 11. Publications: 1.
Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination
ClinicalTrials.gov study NCT04893265. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.